Perioperative Glucose Management for Insulinoma Patients: A Multicenter Retrospective Study of 117 Patients

S. Wu,P. Shang,Z. Wu
DOI: https://doi.org/10.1016/j.hpb.2023.07.572
IF: 3.842
2023-01-01
HPB
Abstract:Purpose: The blood glucose level of insulinoma patients fluctuates significantly in the perioperative period, which is directly related to the prognosis of patients. However, there is still no consensus strategies of perioperative blood glucose control for insulinoma patients. This study analyzed the characteristics of perioperative blood glucose in insulinoma patients and discussed the blood glucose management. Method: The state of art in perioperative blood glucose management of insulinoma were obtained through the nationwide questionnaire. 117 insulinoma patients who underwent surgical resection at the First Affiliated Hospital of Xi 'an Jiaotong University, Xijing Hospital and Tangdu Hospital from January 2010 to October 2019 were enrolled and followed up in this study. The optimal level of perioperative blood glucose management was selected by using the subject working curve. Results: Nationwide questionnaire showed 27.2% (34/125) clinicians lack the understanding of perioperative blood glucose management for insulinoma. A total of 89 patients with complete perioperative glucose data were included in this multicenter study. All tumors were completely resected during operation. Preoperative Blood glucose <3.9mmol/L could be predicted to rise to 2 times after tumor dissection (AUC 0.755). Therefore, patients were divided into the preoperative hypoglycemia group (<3.9mmol/L, n=59) and non-hypoglycemia group (≥3.9mmol/L, n=30). Hypoglycemia group compared with non-hypoglycemia group were more likely to observe a two-fold increase in blood glucose after tumor resection (P < 0.05). But the hypoglycemic group tended to suffer severe hypoglycemia (<3.9mmol/L) than non-hypoglycemic group (57.5% vs6.7%, P<0.05). 57.3% patients developed postoperative rebound hyperglycemia, and long course of disease, segmental pancreatectomy, and high BMI were the risk factors for postoperative rebound hyperglycemia (P < 0.05). Conclusion: Preoperative blood glucose below normal level can effectively observe elevated blood glucose after tumor resection but increase the risk of postoperative hypoglycemic events. Therefore, control blood glucose to near the lower normal limit before surgery is recommended.
What problem does this paper attempt to address?